Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/9/2026

Acute Asthma Management in a 5‑Year‑Old Child (≈12 kg)

Initial Treatment (First 3 Doses)

  • For a 5‑year‑old child weighing ~12 kg with an acute asthma exacerbation, give nebulized salbutamol 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for three consecutive doses; dilute in ≥3 mL saline and deliver with 6–8 L/min oxygen flow【1】【2】.
  • An equivalent press‑urized metered‑dose inhaler (MDI) regimen is 4–8 puffs (90 µg/puff) every 20 minutes for three doses using a spacer and facial mask; this is as effective as nebulization for mild‑to‑moderate attacks【1】【2】【3】.

Maintenance Therapy After Initial Response

  • Mild‑to‑moderate exacerbation: Continue salbutamol nebulization at 0.15–0.30 mg/kg (use 2.5 mg) every 1–4 hours as needed, or 4–8 MDI puffs every 1–4 hours PRN【1】【2】.
  • Severe exacerbation: Consider continuous nebulization at 0.5 mg/kg/h (≈6 mg/h for this child) and add ipratropium bromide 0.25–0.5 mg nebulized every 20 minutes for three doses; ipratropium may be mixed with salbutamol in the same nebulizer【1】【3】.

Systemic Corticosteroid Therapy

  • Oral prednisolone 1–2 mg/kg/day (maximum 60 mg/day) divided into two doses is recommended when there is no rapid bronchodilator response or if the child has used steroids recently【2】【3】.
  • A short course of 3–10 days is sufficient; tapering is unnecessary for courses shorter than one week【3】.

Oxygen Therapy

  • Maintain peripheral oxygen saturation ≥90 % throughout treatment【1】.

Decision‑Making Algorithm by Severity

  • Mild‑to‑moderate (FEV₁ or PEF 40–69 % predicted):
  • Severe (FEV₁ or PEF < 40 % predicted):

Common Pitfalls to Avoid

  • Do not reduce the dose below the minimum 2.5 mg even if weight‑based calculation is lower【1】【2】.
  • Initiate systemic corticosteroids early in moderate‑to‑severe exacerbations【1】【3】.
  • Ipratropium should always be combined with a short‑acting β₂‑agonist; it is not a first‑line monotherapy【3】.
  • Injectable β‑agonists have no proven benefit over aerosolized delivery【1】【2】.
  • Re‑evaluate clinical response after 60–90 minutes of therapy initiation【4】.

Special Considerations for Children < 5 Years

  • Use a well‑fitted facial mask covering nose and mouth for inhalation delivery【5】.
  • Avoid directing nebulized spray toward the eyes【5】.
  • Levalbuterol can be administered at half the salbutamol dose (0.075 mg/kg, minimum 1.25 mg) with comparable efficacy and safety【1】【2】【3】.

Discharge Criteria

  • Child is able to continue inhaled salbutamol as needed.
  • Completed prescribed oral corticosteroid course.
  • Consider initiation of an inhaled corticosteroid regimen.
  • Arrange follow‑up with primary‑care provider within 1–4 weeks【1】【2】.